Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform
Crabb, S. J. Dempsey, L. Soulis, E. Hinsley, S. Song, Yee Pei Barber, J. Frew, J. Gale, J. Faust, G. Brock, S.
Crabb, S. J.
Dempsey, L.
Soulis, E.
Hinsley, S.
Song, Yee Pei
Barber, J.
Frew, J.
Gale, J.
Faust, G.
Brock, S.
Citations
Altmetric:
Abstract
Description
Date
2022
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Crabb SJ, Dempsey L, Soulis E, Hinsley S, Song YP, Barber J, et al. Characterisation of a DNA repair deficiency (DRD) biomarker phenotype in metastatic urothelial carcinoma (mUC) within the ATLANTIS clinical trial platform. Annals of Oncology. 2022 Sep;33(7):S1348-S. PubMed PMID: WOS:000866211602322.